Revista de Osteoporosis y Metabolismo Mineral

metrics 2024

Pioneering Research in Osteoporosis and Metabolic Health

Introduction

Revista de Osteoporosis y Metabolismo Mineral, an esteemed journal published by the SOC ESPANOLA INVESTIGACION OSEA & METABOLISMO MINERAL, stands at the forefront of research in the fields of osteoporosis and mineral metabolism. Established in Spain, this Open Access journal has been providing a platform for the dissemination of innovative research and insights since 2009, ensuring accessibility for all stakeholders in the field. Although currently categorized in the Q4 quartile for Endocrinology, Diabetes and Metabolism (2023), it serves a vital role in fostering academic discourse and collaboration among researchers and healthcare professionals. With its ISSN 1889-836X and E-ISSN 2173-2345, the journal aims to contribute significantly to advancing knowledge and understanding in osteoporosis and associated metabolic disorders. The HIndex is currently not reported, highlighting the journal's emerging impact and potential for growth in the scientific community. Spanning a decade, from 2014 to 2024, the journal’s focus is an invaluable asset for students and professionals seeking to stay informed and engaged in this vital area of medicine.

Metrics 2024

SCIMAGO Journal Rank0.17
Journal Impact Factor0.80
Journal Impact Factor (5 years)0.50
H-Index6
Journal IF Without Self0.80
Eigen Factor0.00
Normal Eigen Factor0.02
Influence0.10
Immediacy Index0.20
Cited Half Life-
Citing Half Life6.40
JCI0.13
Total Documents185
WOS Total Citations85
SCIMAGO Total Citations115
SCIMAGO SELF Citations15
Scopus Journal Rank0.17
Cites / Document (2 Years)0.50
Cites / Document (3 Years)0.42
Cites / Document (4 Years)0.37

Metrics History

Rank 2024

Scopus

Endocrinology, Diabetes and Metabolism in Medicine
Rank #205/244
Percentile 15.98
Quartile Q4

IF (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 161/186
Percentile 13.70
Quartile Q4

JCI (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 169/186
Percentile 9.14
Quartile Q4

Quartile History

Similar Journals

JOURNAL OF BONE AND MINERAL METABOLISM

Connecting disciplines to enhance bone health outcomes.
Publisher: SPRINGER JAPAN KKISSN: 0914-8779Frequency: 6 issues/year

JOURNAL OF BONE AND MINERAL METABOLISM, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing the field of bone and mineral research since its establishment in 1988. With ISSN 0914-8779 and E-ISSN 1435-5604, this esteemed journal offers a platform for high-quality research that intersects Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine, and related disciplines. Recognized for its rigorous standards, it holds a commendable Q2 ranking in multiple categories, reflecting its broad influence and relevance in contemporary medical research. Researchers and practitioners alike benefit from its evidence-based articles and insights, which contribute significantly to our understanding of metabolic bone diseases and mineral homeostasis. Although not an open-access journal, it still provides essential information and advancements crucial for professionals and scholars dedicated to improving clinical outcomes and enhancing patient care in these vital areas. To learn more, please explore the journal's archives and latest publications.

Osteologie

Charting New Frontiers in Osteology
Publisher: GEORG THIEME VERLAG KGISSN: 1019-1291Frequency: 4 issues/year

Osteologie is a distinguished journal published by GEORG THIEME VERLAG KG, focusing on advancing knowledge in the field of osteology and related medical disciplines. With an ISSN of 1019-1291 and E-ISSN 2567-5818, this journal plays a pivotal role in disseminating research that addresses bone health, osteoporotic conditions, and skeletal disorders. Despite its current ranking in Q4 within the broad category of Medicine (miscellaneous), and a Scopus rank placing it at the 15th percentile, Osteologie serves as a platform for emerging research and opinions in a multidisciplinary context. Curating content from 1999 to 2024, it provides valuable insights to researchers, professionals, and students keen on enhancing their understanding of bone health and its implications on overall well-being. With access options available through various academic channels, this journal remains an essential resource for those committed to the exploration and advancement of osteological science.

Austrian Journal of Clinical Endocrinology and Metabolism

Fostering collaboration in endocrinology and metabolism.
Publisher: SPRINGER WIENISSN: 1998-7773Frequency: 4 issues/year

Austrian Journal of Clinical Endocrinology and Metabolism, published by SPRINGER WIEN, serves as a pivotal platform for the dissemination of research in the field of endocrinology, diabetes, and metabolism. With its ISSN 1998-7773 and E-ISSN 1998-7781, this journal has been contributing valuable insights to the field since its inception in 2010. Although it currently holds a Q4 ranking in the category of Endocrinology, Diabetes and Metabolism, it is committed to improving its impact factor by showcasing high-quality, peer-reviewed articles that reflect contemporary challenges and innovations in clinical endocrinology. Located in Vienna, Austria, the journal aims to provide researchers, healthcare professionals, and students with access to the latest findings and clinical practices that advance understanding and treatment of endocrine disorders. Researchers interested in submitting their work will find a supportive environment that embraces both experimental and clinical approaches. The Austrian Journal of Clinical Endocrinology and Metabolism is poised to become a valuable resource for those dedicated to improving health outcomes in metabolic disorders.

CALCIFIED TISSUE INTERNATIONAL

Unveiling breakthroughs in calcified tissue research.
Publisher: SPRINGERISSN: 0171-967XFrequency: 12 issues/year

CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.

Neurological Sciences and Neurophysiology

Elevating the discourse in neurological research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2636-865XFrequency: 4 issues/year

Neurological Sciences and Neurophysiology, published by Wolters Kluwer Medknow Publications, serves as a pivotal platform for dissemination and discussion of recent advancements and research in the fields of neurology and neurophysiology. Since its transition to an Open Access format in 2020, this journal aims to enhance accessibility to crucial developments in neurological sciences for researchers, professionals, and students alike. With an ISSN of 2636-865X, it seeks to bridge the gap between clinical practice and experimental science, promoting innovative approaches to neurological disorders. While currently ranked in the Q4 quartile in the Neurology category, the journal is committed to improving its standing through rigorous peer review and publication of high-quality research. The journal's scope encompasses a wide range of topics, ensuring that it appeals to a diverse audience, while its Scopus ranks indicate its emerging presence in the global scientific community. Located in Mumbai, India, the journal welcomes contributions that push the boundaries of our understanding of the nervous system, making it a vital resource for scholars in this dynamic field.

Annals of Pediatric Endocrinology & Metabolism

Empowering researchers to transform pediatric health.
Publisher: KOREAN SOC PEDIATRIC ENDOCRINOLOGYISSN: 2287-1012Frequency: 4 issues/year

Annals of Pediatric Endocrinology & Metabolism, published by the Korean Society of Pediatric Endocrinology, is a vital resource for researchers, healthcare professionals, and students in the fields of endocrinology, diabetes, and pediatric health. With its commitment to open access since 2012, the journal facilitates the dissemination of groundbreaking research on pediatric endocrine disorders and metabolic diseases, ensuring that vital knowledge is accessible to a global audience. The journal maintains a reputable standing with a 2023 Scopus rank of #92 in Pediatrics and a Q3 quartile in Endocrinology, highlighting its impact on the field. Originating from South Korea, the journal fosters a collaborative network of researchers and advocates best practices in pediatric care through interdisciplinary studies. The Annals not only enhances scientific understanding but also emphasizes practical applications aimed at improving child health outcomes, making it an essential publication for academics and practitioners alike.

DIABETES OBESITY & METABOLISM

Advancing knowledge in diabetes and obesity research.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

JBMR Plus

Fostering innovation in diabetes and orthopedic studies.
Publisher: WILEYISSN: Frequency: 12 issues/year

JBMR Plus, published by Wiley, is a leading open-access journal dedicated to advancing the fields of Endocrinology, Diabetes and Metabolism as well as Orthopedics and Sports Medicine. Since its inception in 2017, JBMR Plus has rapidly gained recognition within the scientific community, achieving prestigious Q1 rankings in both categories as of 2023. This esteemed journal hosts cutting-edge research, providing a platform for innovative studies that explore the intersections of bone health, metabolism, and athletic performance. With a robust Scopus ranking, where it stands in the top percentiles for its specialties, JBMR Plus aims to disseminate knowledge and foster collaborations among researchers, healthcare professionals, and students dedicated to improving patient outcomes. Researchers worldwide can access its content freely, ensuring that crucial findings reach a diverse audience, contributing significantly to the discourse in these vital medical fields.

Lancet Diabetes & Endocrinology

Empowering researchers in diabetes and endocrinology.
Publisher: ELSEVIER SCIENCE INCISSN: 2213-8587Frequency: 12 issues/year

Lancet Diabetes & Endocrinology is a premier peer-reviewed journal, published by Elsevier Science Inc, dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Established in 2013, this journal has quickly ascended to a position of notable prestige, reflected in its prestigious Q1 rank across various categories, including Endocrinology, Internal Medicine, and Diabetes & Metabolism. With an impressive impact factor and Scopus rankings placing it in the 99th percentile of its field, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal aims to disseminate high-quality research covering clinical and experimental aspects of metabolic and endocrine disorders, making it an indispensable tool for those looking to stay at the forefront of these rapidly evolving fields. With its focus on innovative depth and cutting-edge studies, Lancet Diabetes & Endocrinology continually fosters an international dialogue critical for advancements in diabetes and endocrinology.

OSTEOPOROSIS INTERNATIONAL

Unlocking New Perspectives on Bone Health
Publisher: SPRINGER LONDON LTDISSN: 0937-941XFrequency: 12 issues/year

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.